银屑病关节炎中的葡萄膜炎:单中心406例患者研究及文献综述
本研究回顾性纵向分析了单中心406例银屑病关节炎(PsA)患者,葡萄膜炎患病率约4.9%,均为急性前部、单侧且半数复发。葡萄膜炎与HLA-B27阳性、MRI骶髂关节炎及更差的疾病影响和功能残疾相关。暴露调整发病率在抗TNFα单克隆抗体治疗后下降,而依那西普和司库奇尤单抗治疗后升高。
要点
- PsA患者中葡萄膜炎患病率约4.9%,均为急性前部、单侧,50%复发。
- 葡萄膜炎患者HLA-B27阳性率45% vs 7.5%,MRI骶髂关节炎25% vs 8.3%。
- 抗TNFα单克隆抗体后葡萄膜炎发病率下降(56.3 vs 9.4/100患者年),依那西普和司库奇尤单抗后升高。
核心结论
- PsA中葡萄膜炎患病率约5%,表现与ax-SpA相似,与更差的生活质量和更大的功能残疾相关。
- 葡萄膜炎暴露调整发病率在抗TNFα单克隆抗体治疗后下降,在依那西普和司库奇尤单抗治疗后升高。
研究设计与样本
- 单中心回顾性纵向研究,纳入406例按CASPAR标准分类的PsA患者,葡萄膜炎由经验丰富的眼科医生诊断,并进行文献综述。
主要发现
- 406例PsA患者(46.3±12.3岁)中20例(4.9%)观察到葡萄膜炎,均为急性、前部(80%)、单侧(80%)和复发(50%)。
- 葡萄膜炎患者HLA-B27阳性率45% vs 无葡萄膜炎者7.5%(p<0.0001),MRI骶髂关节炎25% vs 8.3%(p=0.027),眼表病变10% vs 0.8%(p=0.021)。
- 葡萄膜炎患者PsA影响疾病评分中位数5.9(2.1-6.8) vs 1.25(0.0-3.0)(p=0.001),Bath强直性脊柱炎功能指数中位数4(1.6-5) vs 1.0(0.0-3.5)(p=0.01)。
- 葡萄膜炎暴露调整发病率(每100患者年发作次数)生物治疗前 vs 后:抗TNFα单克隆抗体56.3 vs 9.4,依那西普6.03 vs 24.2,司库奇尤单抗0 vs 50(后两者仅包括1例患者)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/PURPOSE: The manifestations of uveitis are well established in axial spondyloarthritis (ax-SpA), but not in psoriatic arthritis (PsA). We aimed to assess, in a large unselected series of PsA: (A) the frequency and clinical features of uveitis; (B) its association with PsA activity, the impact of disease and functional disability, and (C) its relationship with the biological treatment. In addition, a literature review was performed. METHODS: Retrospective longitudinal study of PsA patients from a single referral hospital. PsA was classified according to the CASPAR criteria, and uveitis was diagnosed by experienced ophthalmologists. RESULTS: We studied 406 patients with PsA (46.3±12.3 years). Uveitis was observed in 20 (4.9%). Uveitis was acute in all cases, anterior (80%), unilateral (80%) and recurrent (50%). Patients with uveitis had a higher prevalence of HLA-B27 (45% vs 7.5%, p<0.0001), sacroiliitis on MRI (25% vs 8.3% p=0.027), ocular surface pathology (10% vs 0.8%, p=0.021), and median PsA impact of Disease Score (5.9 (2.1-6.8) vs 1.25 (0.0-3.0), p=0.001) and Bath Ankylosing Spondylitis Functional Index (4 (1.6-5) vs 1.0 (0.0-3.5), p=0.01) than patients without uveitis.The exposure adjusted incidence rate (episodes/100 patients-year) of uveitis before versus after biological treatment decreased with anti-TNFα monoclonal antibodies (56.3 vs 9.4) and increased with etanercept (ETN) (6.03 vs 24.2) and secukinumab (SECU) (0 vs 50) (including only one patient treated in the last two cases). CONCLUSION: The prevalence of uveitis in patients with PsA was about 5%. The pattern was similar to that observed in ax-SpA. Uveitis was associated with a worse quality of life and greater functional disability. The uveitis exposure adjusted incidence rate decreased with anti-TNFα monoclonal antibodies and increased with ETN and SECU.
引用
- De Vicente Delmás A, Sanchez-Bilbao L, Calvo-Río V, et al. Uveitis in psoriatic arthritis: study of 406 patients in a single university center and literature review. RMD Open. 2023. PMID: 36635002. doi:10.1136/rmdopen-2022-002781
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。